We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Molson Coors Class B
TAP
$7.33B
| $7K | ﹤0.01% |
122
| – | – |
2022 Q1
7 quarters
|
|
1027
Vanguard International Dividend Appreciation ETF
VIGI
$9.02B
| $7K | ﹤0.01% |
+90
| New | +$6.63K |
2023 Q4
0 quarters
|
|
1028
W.R. Berkley Corp 5.10% Subordinated Debentures due 2059
WRB.PRF
$209M
| $7K | ﹤0.01% |
+277
| New | +$5.84K |
2023 Q4
0 quarters
|
|
1029
DELISTED
WW International
WW
| $7K | ﹤0.01% |
800
| – | – |
2022 Q1
7 quarters
|
|
1030
Clean Harbors
CLH
$16.7B
| $6K | ﹤0.01% |
35
| – | – |
2023 Q1
3 quarters
|
|
1031
Dollar Tree
DLTR
$23.1B
| $6K | ﹤0.01% |
44
| – | – |
2022 Q1
7 quarters
|
|
1032
Embecta
EMBC
$352M
| $6K | ﹤0.01% |
338
-120
| -26% | -$1.97K |
2022 Q2
6 quarters
|
|
1033
iShares US Pharmaceuticals ETF
IHE
$1.53B
| $6K | ﹤0.01% |
90
| – | – |
2022 Q1
7 quarters
|
|
1034
Modine Manufacturing
MOD
$7.95B
| $6K | ﹤0.01% |
+100
| New | +$4.89K |
2023 Q4
0 quarters
|
|
1035
NBT Bancorp
NBTB
$2.63B
| $6K | ﹤0.01% |
138
| – | – |
2022 Q1
7 quarters
|
|
1036
Intellia Therapeutics
NTLA
$1.62B
| $6K | ﹤0.01% |
200
| – | – |
2022 Q1
7 quarters
|
|
1037
Invesco S&P MidCap 400 Pure Value ETF
RFV
$334M
| $6K | ﹤0.01% |
52
+50
| +2,500% | +$5.11K |
2023 Q3
1 quarter
|
|
1038
ROBO Global Robotics & Automation Index ETF
ROBO
$1.91B
| $6K | ﹤0.01% |
100
| – | – |
2022 Q1
7 quarters
|
|
1039
Sylvamo
SLVM
$1.25B
| $6K | ﹤0.01% |
115
| – | – |
2022 Q1
7 quarters
|
|
1040
State Street SPDR Portfolio TIPS ETF
SPIP
$1.05B
| $6K | ﹤0.01% |
243
| – | – |
2022 Q3
5 quarters
|
|
1041
UGI
UGI
$8.17B
| $6K | ﹤0.01% |
242
| – | – |
2022 Q1
7 quarters
|
|
1042
DELISTED
Orange
ORAN
| $6K | ﹤0.01% |
500
| – | – |
2023 Q3
1 quarter
|
|
1043
DELISTED
Splunk Inc
SPLK
| $6K | ﹤0.01% |
+40
| New | +$5.98K |
2023 Q4
0 quarters
|
|
1044
DELISTED
CITIGROUP INC. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.125% Fixed Rate / Floating Rate Noncumulative Preferred Stock, Series J
C.PRJ
| $6K | ﹤0.01% |
232
-168
| -42% | -$4.3K |
2022 Q1
7 quarters
|
|
1045
iShares USD Green Bond ETF
BGRN
$490M
| $5K | ﹤0.01% |
115
| – | – |
2023 Q2
2 quarters
|
|
1046
Coca-Cola Europacific Partners
CCEP
$49.2B
| $5K | ﹤0.01% |
82
| – | – |
2022 Q1
7 quarters
|
|
1047
Evergy
EVRG
$18.8B
| $5K | ﹤0.01% |
89
| – | – |
2022 Q1
7 quarters
|
|
1048
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$475M
| $5K | ﹤0.01% |
59
+57
| +2,850% | +$4.87K |
2023 Q3
1 quarter
|
|
1049
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$571M
| $5K | ﹤0.01% |
78
+26
| +50% | +$1.66K |
2023 Q2
2 quarters
|
|
1050
M&T Bank
MTB
$30.9B
| $5K | ﹤0.01% |
36
| – | – |
2013 Q2
42 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.